Drug Database
Back to search

Belgium· BE-AMP-SAM313591-00

Adreview 74 MBq/ml

A iobenguane (123i) product containing iobenguane (123 i), registered in Belgium by GE Healthcare. The same ATC class is registered in 9 of our 19 countries.

ATC V09IX01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAdreview 74 MBq/mlATCV09IX01REGISTER NO.BE-AMP-SAM313591-00PACKS LISTED11CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about iobenguane (123 i)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Iobenguane (123i) is registered in 9 of 19 countries.

Countries holding a registration under ATC V09IX01 (iobenguane (123i)), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 5 of them publish a price we can compare per daily dose
Search iobenguane (123i) products by name

Iobenguane (123i) · ATC V09IX01

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Iobenguane (123 I)
Manufacturer
GE Healthcare
Country
Belgium (BE)
ATC code
V09IX01
ATC class
Iobenguane (123I)
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 11

  • be_apb
    4665360
  • be_apb
    3334679
  • be_apb
    3334687
  • be_apb
    3334653
  • be_apb
    3334711
  • be_apb
    3334737
  • be_apb
    3334695
  • be_apb
    3334703
  • be_apb
    3334760
  • be_apb
    3334745
  • be_apb
    3334752

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

241 interactions on record for iobenguane (123i).

Graded by severity as the source publishes them — 143 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check iobenguane (123i) against other medicinesHow interaction checks work

Iobenguane (123i) · interactions on record

241 records

  • 143 severe
  • 98 moderate

Most severe, free to view

  • PhentermineA08AA01severe
  • FenfluramineA08AA02severe
  • DexfenfluramineA08AA04severe
  • MazindolA08AA05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Iobenguane (123i) in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All iobenguane (123i) products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Czechia · Mibg (I123) Curium Netherlands
  • Germany · Adreview
  • Denmark · Adreview, Mibg (123i) Curium Netherlands
  • Spain · Adreview, Mibg (123i) Curium Pharma Spain
  • France · Adreview (123i), Mibg (123i) Curium Netherlands
  • United Kingdom (Northern Ireland) · Adreview, Mibg (123i) Curium Netherlands
  • Hungary · [123i]-Mibg, [123i]-Mibg Curium Netherlands
  • Ireland · Mibg (123i) Curium Netherlands
  • Italy · [123i]-Mibg, Adreview
  • Luxembourg · Adreview
  • Netherlands · Adreview, Mibg (I123) Jobenguaan Curium Netherlands
  • Norway · Adreview
  • Slovakia · 123i Mibg Inj

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/acfcffc4-e4be-41a5-b4b9-11f0dcb67ac5
GET /v1/drugs/acfcffc4-e4be-41a5-b4b9-11f0dcb67ac5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Adreview 74 MBq/ml",
  "name_fr": "Adreview 74 MBq/ml",
  "name_nl": "Adreview 74 MBq/ml",
  "amp_code": "SAM313591-00",
  "strengths": [
    "74.0000",
    "0.0001",
    "0.0103",
    "0.0028",
    "0.0227"
  ],
  "pack_count": 11,
  "substances": [
    "Iobenguane (123 I)",
    "Iobenguane Sulfate",
    "Benzyl Alcohol",
    "Disodium Hydrogen Phosphate Dihydrate",
    "Sodium Dihydrogen Phosphate Dihydrate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Iobenguane (123I)",
  "authorisation_numbers": [
    "BE313591"
  ]
}
API referenceMCP serverPlans

See everything about iobenguane (123i).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console